Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 2
2007 1
2008 2
2009 2
2010 3
2011 6
2012 8
2013 6
2014 7
2015 3
2016 4
2017 5
2018 5
2019 3
2020 12
2021 6
2022 10
2023 8
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Long-term survival for lymphoid neoplasms and national health expenditure (EUROCARE-6): a retrospective, population-based study.
Sant M, Vener C, Lillini R, Rossi S, Bonfarnuzzo S, Marcos-Gragera R, Maynadié M, Innos K, Paapsi K, Visser O, Bernasconi A, Demuru E, Di Benedetto C, Mousavi SM, Blum M, Went P, Serraino D, Bennett D, Sánchez MJ, De Angelis R; EUROCARE-6 Working Group. Sant M, et al. Lancet Oncol. 2024 May 1:S1470-2045(24)00141-4. doi: 10.1016/S1470-2045(24)00141-4. Online ahead of print. Lancet Oncol. 2024. PMID: 38703784
Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study.
De Angelis R, Demuru E, Baili P, Troussard X, Katalinic A, Chirlaque Lopez MD, Innos K, Santaquilani M, Blum M, Ventura L, Paapsi K, Galasso R, Guevara M, Randi G, Bettio M, Botta L, Guzzinati S, Dal Maso L, Rossi S; EUROCARE-6 Working Group. De Angelis R, et al. Lancet Oncol. 2024 Mar;25(3):293-307. doi: 10.1016/S1470-2045(23)00646-0. Epub 2024 Jan 30. Lancet Oncol. 2024. PMID: 38307102
Significantly reduced incidence and improved survival from prostate cancer over 25 years.
Serdà-Ferrer BC, Sanvisens A, Fuentes-Raspall R, Puigdemont M, Farré X, Vidal-Vila A, Rispau-Pagès M, Baltasar-Bagué A, Marcos-Gragera R. Serdà-Ferrer BC, et al. Among authors: sanvisens a. BMC Public Health. 2023 Dec 21;23(1):2552. doi: 10.1186/s12889-023-17440-7. BMC Public Health. 2023. PMID: 38129873 Free PMC article.
Incidence and time trends of childhood hematological neoplasms: a 36-year population-based study in the southern European context, 1983-2018.
Trallero J, Sanvisens A, Almela Vich F, Jeghalef El Karoni N, Saez Lloret I, Díaz-Del-Campo C, Marcos-Navarro AI, Aizpurua Atxega A, Sancho Uriarte P, De-la-Cruz Ortega M, Sánchez MJ, Perucha J, Franch P, Chirlaque MD, Guevara M, Ameijide A, Galceran J, Ramírez C, Camblor MR, Alemán MA, Gutiérrez P, Marcos-Gragera R; REDECAN. Trallero J, et al. Among authors: sanvisens a. Front Oncol. 2023 Jul 25;13:1197850. doi: 10.3389/fonc.2023.1197850. eCollection 2023. Front Oncol. 2023. PMID: 37560466 Free PMC article.
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder.
Hernández-Rubio A, Sanvisens A, Barbier-Torres L, Blanes R, Miquel L, Torrens M, Rubio G, Bolao F, Zuluaga P, Fuster D, Rodríguez de Fonseca F, Farré M, Muga R; CohRTA. Hernández-Rubio A, et al. Among authors: sanvisens a. Drug Alcohol Depend. 2023 Apr 1;245:109822. doi: 10.1016/j.drugalcdep.2023.109822. Epub 2023 Feb 24. Drug Alcohol Depend. 2023. PMID: 36893509 Free article.
Cancer treatment data available in European cancer registries: Where are we and where are we going?
Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, Arndt V, Francisci S, Dochez C, Ribes J, Fernández LP, Gavin A, Gatta G, Marcos-Gragera R, Lievens Y, Allemani C, De Angelis R, Visser O, Van Eycken L; ENCR Working Group on Treatment Data Harmonisation. Giusti F, et al. Among authors: sanvisens a. Front Oncol. 2023 Feb 8;13:1109978. doi: 10.3389/fonc.2023.1109978. eCollection 2023. Front Oncol. 2023. PMID: 36845700 Free PMC article.
85 results